pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Preclinical
XYA-01
Triple-Negative Breast Cancer (TNBC)
Xyone Therapeutics Inc
Preclinical
XYA-02
Pancreatic Ductal Adenocarcinoma
Xyone Therapeutics Inc
Phase 2
XmAb bispecific antibody
Unspecified Cancer
$NVS
NOVARTIS AG
Preclinical
← prev
page 39 of 62
next →
Pain
89
Neurology
1
YB-200
Hepatocellular Carcinoma
Ymmunobio AG
Phase 1
YENEO-001
Colorectal Cancer
NantBio Inc
Phase 1
YH-013
Solid Tumor
Eucure (Beijing) Biopharma Co Ltd
Phase 2
YH-42946
Non-Small Cell Lung Cancer
Yuhan Corp
Phase 2
YL-13027
Solid Tumor
Shanghai Yingli Pharmaceutical Co Ltd
Phase 2
YL-15293
Colorectal Cancer
Shanghai Yingli Pharmaceutical Co Ltd
Phase 1
YL-217
Colorectal Cancer
Suzhou Medilink Therapeutics Ltd
Marketed
Yonsa
Yonsa (abiraterone acetate)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sun Pharmaceutical Industries Ltd
Phase 2
ZEN-3694
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Zenith Epigenetics Ltd
Phase 1
ZH9
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…
Prokarium Ltd
Preclinical
ZL-1311
Gastric Cancer
$ZLAB
Zai Lab Ltd
Phase 1
ZL-6201
Breast Cancer
$ZLAB
Zai Lab Ltd
Phase 1
ZM-008
Bile Duct Cancer (Cholangiocarcinoma)
Zumutor Biologics Inc
Phase 1
ZW-191
Endometrial Cancer
$ZYME
Zymeworks Inc.
Phase 1
ZW-251
Hepatocellular Carcinoma
$ZYME
Zymeworks Inc.
Phase 2
abefolastat tesaroxetan
abefolastat tesaroxetan
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Clarity Pharmaceuticals Ltd
Marketed
abemaciclib
Verzenio (abemaciclib)
Human Epidermal Growth Factor Receptor 2 Negative Breast…
Eli Lilly and Co
Phase 2
abequolixron zinc
abequolixron zinc
Epithelial Ovarian Cancer
Inspirna Inc
Phase 3
abexinostat
abexinostat
Metastatic Renal Cell Carcinoma
Xynomic Pharmaceuticals Holdings Inc
Phase 2
acimtamig
acimtamig [INN]
Anaplastic Large Cell Lymphoma (ALCL)
Affimed GmbH
Phase 2
actinium (225Ac) lintuzumab satetraxetan
Actimab A (actinium (225Ac) lintuzumab satetraxetan [INN])
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$ATNM
Actinium Pharmaceuticals, Inc.
Marketed
adagrasib
Krazati (adagrasib)
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
Phase 2
adrixetinib
adrixetinib [INN]
Solid Tumor
Qurient Co Ltd
Phase 2
afamitresgene autoleucel
Tecelra (afamitresgene autoleucel)
Myxoid Liposarcoma
US WorldMeds LLC
Preclinical
afatinib + palbociclib
afatinib [INN] + palbociclib
Chordoma
Collaborations Pharmaceuticals Inc
Marketed
afatinib dimaleate
Gilotrif (afatinib dimaleate)
Non-Small Cell Lung Cancer
Boehringer Ingelheim Corp
Phase 3
afuresertib hydrochloride
afuresertib hydrochloride
Human Epidermal Growth Factor Receptor 2 Negative Breast…
Laekna Inc
